Annual Meeting of the Japan Society of Clinical Oncology
Disclosure of Conflict of Interest
Name of first author： ○○ ○○
Matters requiring disclosure of COI
with regard to our presentation are as follows;
Research founding：○○ Pharma Co. Limit.
Acceptance of Researchers： ○○ Pharma Inc.

Document

Document

PowerPoint プレゼンテーション

Legal Trainee

栗田 壮太氏 （ランクセス株式会社サルティゴ医薬担当）

Disclosure Information Name of Meeting Name of

Document

www2.convention.co.jp

Document

Document

Duk Soon Choi, Vice President Preformulation, Kashiv

Outcubation—where incubation meets outsourcing

1st BME GLOBAL PHARMA SUPPLY CHAIN CONGRESS 2016

Topics: • Accessing Innovation: how to build efficient

Pharma 400 USP - BRENNTAG SPECIALTIES, Inc.

Dissolution Rate Testing

Pharma 200 USP - BRENNTAG SPECIALTIES, Inc.

Mit PGS.pharma das passende Medikament finden

Amino Acid Analysis - GBA

ZS ASN Teaser

Company Fact Sheet

Document